Shopping Cart
- Remove All
Your shopping cart is currently empty
OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $30 | In Stock | |
| 25 mg | $64 | In Stock | |
| 50 mg | $112 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock |
| Description | OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay. |
| Targets&IC50 | D3 receptor:0.2 nM (Ki) |
| In vitro | The effect of OS-3-106 (10 mg/kg) on the dose-response function of cocaine self-administration.?OS-3-106 decreased cocaine and sucrose reinforcement rates, increased latency to first response for cocaine but not sucrose, and downshifted the cocaine self-administration dose-response function.?Thish compounds blocked a D3R-mediated behavior. |
| Molecular Weight | 450.6 |
| Formula | C25H30N4O2S |
| Cas No. | 1580000-17-4 |
| Smiles | COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2cscn2)CC1 |
| Relative Density. | 1.185 g/cm3 (Predicted) |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 4.51 mg/mL (10.01 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.